Abstract

Induced regulatory T cells (iTreg) are a heterogeneous T-cell subset that is induced during an allo-response and down-regulates the immune response. iTreg are commonly characterized as CD4+CD25high, CD4+CD25highFoxP3+, CD4+CD25highCD127−, or CD4+CD25highFoxP3+CD127− peripheral blood lymphocytes (PBL). In the present study, we investigated the overlap of these 4 phenotypically determined iTreg subsets in normal human individuals. PBL of 8 healthy individuals were incubated for 0 hours (Group 1) or for 16 hours in medium without (Group 2) or with phorbol 12-myristate 13-acetate (PMA)/Ionomycin (Group 3). Thereafter, proportions of PBL with Treg phenotypes were determined using 4-color flow-cytometry. All 4 Treg subsets increased strongly during polyclonal stimulation (P < .001). After stimulation, combining 2 iTreg markers, 24% of stimulated CD4+ PBL were CD25highFoxP3+, 18% CD25highCD127−, and 61% FoxP3+CD127−. Combining 3 iTreg markers, only 18% of the polyclonally stimulated CD4+ PBL were CD25highFoxP3+CD127−. Importantly, the proportion of FoxP3+CD127− PBL increased with the quantity of CD25 on stimulated CD4+ PBL and was highest in CD25high PBL (P = .002), emphasizing the relevance of CD25high as iTreg marker. Different iTreg phenotypes should not be used interchangeably because they define different iTreg subsets that overlap only in part. CD25high is the most relevant iTreg marker. These conclusions should be considered when studies and experiments involving iTreg phenotypes are compared.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.